Evaluating first-line immuno-oncology-based treatments for metastatic renal cell carcinoma in real world clinical practice using pre-treatment G8 scores

被引:0
|
作者
Sazuka, Tomokazu [1 ]
Arai, Takayuki [1 ]
Sato, Hiroaki [1 ]
Goto, Yusuke [1 ]
Sakamoto, Shinichi [1 ]
Ichikawa, Tomohiko [1 ]
机构
[1] Chiba Univ, Dept Urol, Grad Sch Med, Chiba, Japan
关键词
D O I
10.1111/iju.15249
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1054 / 1056
页数:3
相关论文
共 50 条
  • [1] Real-world comparison of first-line treatments for metastatic clear cell renal cell carcinoma (mccRCC)
    Yazdanpanah, Omid
    Dwabe, Sami
    Harada, Garrett
    Seyedin, Steven
    Mar, Nataliya
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.
    De Vries, Manon
    Hamilou, Zineb
    Ghosh, Sunita
    Heng, Daniel Yick Chin
    Wood, Lori
    Basappa, Naveen S.
    Kollmannsberger, Christian K.
    Graham, Jeffrey
    Bhindi, Bimal
    Finelli, Antonio
    Bjarnason, Georg A.
    Bosse, Dominick
    Pouliot, Frederic
    Castonguay, Vincent
    Breau, Rodney H.
    Saleh, Ramy R.
    Winquist, Eric
    Lalani, Aly-Khan A.
    Soulieres, Denis
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [3] Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma
    Wells, J. Connor
    Graham, Jeffrey
    Beuselinck, Benoit
    Bjarnason, Georg A.
    Donskov, Frede
    Hansen, Aaron R.
    McKay, Rana R.
    Vaishampayan, Ulka
    De Velasco, Guillermo
    Duh, Mei S.
    Huynh, Lynn
    Nguyen, Catherine
    Zanotti, Giovanni
    Ramaswamy, Krishnan
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : E350 - E359
  • [4] First-line Treatment of Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: Systematic Review and Network Meta-analysis
    Monteiro, Fernando Sabino M.
    Soares, Andrey
    Debiasi, Marcio
    Schutz, Fabio A.
    Maluf, Fernando Cotait
    Bastos, Diogo Assed
    Sasse, Andre
    Cauduro, Carolina G. S.
    Mendes, Gabriela Oliveira
    Ziegelmann, Patricia K.
    Fay, Andre P.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (04) : 244 - +
  • [5] Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis
    Heseltine, Jonathan
    Allison, Jennifer
    Wong, Sam
    Prasad, Kellati
    Oong, Zhu-Chuen
    Wong, Helen
    Law, Andrea
    Charnley, Natalie
    Parikh, Omi
    Waddell, Tom
    Chow, Shien
    TARGETED ONCOLOGY, 2023, 18 (04) : 593 - 599
  • [6] Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis
    Jonathan Heseltine
    Jennifer Allison
    Sam Wong
    Kellati Prasad
    Zhu-Chuen Oong
    Helen Wong
    Andrea Law
    Natalie Charnley
    Omi Parikh
    Tom Waddell
    Shien Chow
    Targeted Oncology, 2023, 18 : 593 - 599
  • [7] Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell Carcinoma
    Lee, Sangmin
    Kim, Jae-Hun
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Il Seo, Seong
    Jeon, Seong Soo
    Park, Se Hoon
    Lee, Ji Hyun
    Yu, Jiwoong
    Kang, Minyong
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 1091 - 1101
  • [8] First-Line Immuno-Oncology Combinations for Metastatic Clear Cell Renal Cell Carcinoma (mRCC): A Systematic Review of Phase III Clinical Trials
    Hahn, Andrew W.
    Shah, Amishi Y.
    Campbell, Matthew T.
    KIDNEY CANCER, 2021, 5 (04) : 207 - 217
  • [9] SUNITINIB TREATMENT MODIFICATION IN FIRST-LINE METASTATIC RENAL CELL CARCINOMA: ANALYSIS OF A REAL-WORLD SWEDISH COHORT
    Jakobsson, M.
    Nilsson, F.
    Strambi, A.
    Arpegard, J.
    Dalen, J.
    VALUE IN HEALTH, 2022, 25 (01) : S22 - S22
  • [10] SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE (RWE) STUDIES FOR FIRST-LINE TREATMENTS IN ADVANCED OR METASTATIC RENAL CELL CARCINOMA
    Bregman, C.
    Supiot, R.
    Pacou, M.
    Doan, J.
    Dale, P.
    Malcolm, B.
    VALUE IN HEALTH, 2018, 21 : S20 - S20